Skip to main content
SpringerLink
Log in

Anticoagulation, Resuscitation, and Hemostasis

  • Chapter
  • First Online:
Clinical Review of Vascular Trauma

  • 2194 Accesses

Abstract

Hemorrhage remains a major cause of potentially preventable deaths. Trauma and massive transfusion are associated with coagulopathy secondary to tissue injury, hypoperfusion, dilution, and consumption of clotting factors and platelets. Damage control surgery prioritizes early mechanical control of bleeding, while hemostatic resuscitation seeks mitigating the damage caused by a coagulopathy through blood product transfusions. Although early and effective reversal of coagulopathy is documented, the most effective means of preventing coagulopathy of massive transfusion remains debated, and randomized controlled studies are lacking. Viscoelastic whole blood assays like thromboelastography (TEG) and rotational thromboelastometry (ROTEM) can diagnose coagulopathy earlier than other assays. Patients with uncontrolled bleeding who have had an optimal surgical intervention should be treated with hemostatic control resuscitation with early administration of plasma, platelets, and RBCs; this strategy should be guided by TEG/ROTEM analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma. 2008;65:951–60.

    Article  PubMed  Google Scholar 

  2. Stern SA, Dronen SC, Birrer P, Wang X. Effect of blood pressure on hemorrhage volume and survival in a near-fatal hemorrhage model incorporating a vascular injury. Ann Emerg Med. 1993;22:155–63.

    Article  PubMed  CAS  Google Scholar 

  3. Dries DJ. Hypotensive resuscitation. Shock. 1996;6:311–6.

    Article  PubMed  CAS  Google Scholar 

  4. Dutton RP. Resuscitative strategies to maintain homeostasis during damage control surgery. Br J Surg. 2012;99 Suppl 1:21–8. doi:10.1002/bjs.7731.

    Article  PubMed  Google Scholar 

  5. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208.

    Article  Google Scholar 

  6. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723–40.

    Article  PubMed  Google Scholar 

  7. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg. 2007;105:905–17.

    Article  PubMed  CAS  Google Scholar 

  8. Knotzer H, Pajk W, Maier S, Dunser MW, Ulmer H, Schwarz B, Salak N, Hasibeder WR. Comparison of lactated Ringer’s, gelatine and blood resuscitation on intestinal oxygen supply and mucosal tissue oxygen tension in haemorrhagic shock. Br J Anaesth. 2006;97:509–16.

    Article  PubMed  CAS  Google Scholar 

  9. Thorsen K, Ringdal KG, Strand K, Soreide E, Hagemo J, Soreide K. Clinical and cellular effects of hypothermia, acidosis and coagulopathy in major injury. Br J Surg. 2011;98:894–907.

    Article  PubMed  CAS  Google Scholar 

  10. Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG, Billiar TR, Peitzman AB, Moore EE, Cohen MJ, Sperry JL. Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way. J Trauma Acute Care Surg. 2012;72:892–8.

    PubMed  Google Scholar 

  11. Duchesne JC, Guidry C, Hoffman JR, Park TS, Bock J, Lawson S, Meade P, McSwain Jr NE. Low-volume resuscitation for severe intraoperative hemorrhage: a step in the right direction. Am Surg. 2012;78:936–41.

    PubMed  Google Scholar 

  12. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand. 2005;49:1163–71.

    Article  PubMed  CAS  Google Scholar 

  13. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg. 2011;112:635–45.

    Article  PubMed  CAS  Google Scholar 

  14. Hess JR. Massive transfusion for trauma: opportunities and risks. ISBT Science Series. 2008;3:197–201.

    Article  Google Scholar 

  15. Wolberg AS, Meng ZH, Monroe III DM, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma. 2004;56:1221–8.

    Article  PubMed  CAS  Google Scholar 

  16. Yoshihara H, Yamamoto T, Mihara H. Changes in coagulation and fibrinolysis occurring in dogs during hypothermia. Thromb Res. 1985;37:503–12.

    Article  PubMed  CAS  Google Scholar 

  17. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748–54.

    Article  PubMed  CAS  Google Scholar 

  18. Djaldetti M, Fishman P, Bessler H, Chaimoff C. pH-induced platelet ultrastructural alterations. A possible mechanism for impaired platelet aggregation. Arch Surg. 1979;114:707–10.

    Article  PubMed  CAS  Google Scholar 

  19. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg. 2007;246:831–5.

    Article  PubMed  Google Scholar 

  20. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54:1127–30.

    Article  PubMed  Google Scholar 

  21. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211–7.

    Article  PubMed  Google Scholar 

  22. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245:812–8.

    Article  PubMed  Google Scholar 

  23. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypotheses. 2010;75:564–7.

    Article  PubMed  CAS  Google Scholar 

  24. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194–200.

    Article  PubMed  Google Scholar 

  25. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol. 2009;145:24–33.

    Article  PubMed  CAS  Google Scholar 

  26. Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma. 2006;60:S12–9.

    Article  PubMed  Google Scholar 

  27. Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15:R272.

    Article  PubMed  Google Scholar 

  28. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost. 2001;27:585–92.

    Article  PubMed  CAS  Google Scholar 

  29. Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67:125–31.

    Article  PubMed  Google Scholar 

  30. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252:434–42.

    PubMed  Google Scholar 

  31. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.

    Article  PubMed  CAS  Google Scholar 

  32. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167:1414–9.

    Article  PubMed  Google Scholar 

  33. Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ. Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial. Ann Intern Med. 2011;155:660–7, W204.

    Article  PubMed  Google Scholar 

  34. Huang J, Cao Y, Liao C, Wu L, Gao F. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials. Thromb Haemost. 2011;105:245–53.

    Article  PubMed  CAS  Google Scholar 

  35. Duggan ST. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery. Am J Cardiovasc Drugs. 2012;12:57–72.

    Article  PubMed  CAS  Google Scholar 

  36. Levi M, Eerenberg ES, Kampuisen PW. Anticoagulants. Old and new. Hamostaseologie. 2011;31:229–35.

    Article  PubMed  CAS  Google Scholar 

  37. Cotton BA, McCarthy JJ, Holcomb JB. Acutely injured patients on dabigatran. N Engl J Med. 2011;365:2039–40.

    Article  PubMed  Google Scholar 

  38. Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Thromb Haemost. 2012;108:583–5.

    Article  PubMed  Google Scholar 

  39. Boland M, Murphy M, Murphy M, McDermott E. Acute-onset severe gastrointestinal tract hemorrhage in apostoperative patient taking rivaroxaban after total hip arthroplasty: a case report. J Med Case Rep. 2012;6:129.

    Article  PubMed  Google Scholar 

  40. Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012;73:60–6.

    Article  PubMed  CAS  Google Scholar 

  41. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116:1896–906.

    Article  PubMed  CAS  Google Scholar 

  42. Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos CK, Perry D, Burroughs AK. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis. 2007;18:227–36.

    Article  PubMed  CAS  Google Scholar 

  43. Spinler SA, Rees C. Review of prasugrel for the secondary prevention of atherothrombosis. J Manag Care Pharm. 2009;15:383–95.

    PubMed  Google Scholar 

  44. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost. 2006;32 Suppl 1:32–8.

    Article  PubMed  CAS  Google Scholar 

  45. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol. 2009;22:267–74.

    Article  PubMed  Google Scholar 

  46. Murray D, Pennell B, Olson J. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion. 1999;39:56–62.

    Article  PubMed  CAS  Google Scholar 

  47. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005;45:1413–25.

    Article  PubMed  Google Scholar 

  48. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis. 2001;12:327–37.

    Article  PubMed  CAS  Google Scholar 

  49. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med. 2009;17:45.

    Article  PubMed  Google Scholar 

  50. Plotkin AJ, Wade CE, Jenkins DH, Smith KA, Noe JC, Park MS, Perkins JG, Holcomb JB. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma. 2008;64:S64–8.

    Article  PubMed  Google Scholar 

  51. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, Kheirabadi BS, Pusateri AE, Vos JA, Guymon CH, Wolf SE, Mann KG, Holcomb JB. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67:266–75.

    Article  PubMed  Google Scholar 

  52. Ostrowski SR, Sorensen AM, Larsen CF, Johansson PI. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med. 2011;19:64.

    Article  PubMed  Google Scholar 

  53. Gaarder C, Naess PA, Frischknecht CE, Hakala P, Handolin L, Heier HE, Ivancev K, Johansson P, Leppaniemi A, Lippert F, Lossius HM, Opdahl H, Pillgram-Larsen J, Roise O, Skaga NO, Soreide E, Stensballe J, Tonnessen E, Tottermann A, Ortenwall P, Ostlund A. Scandinavian guidelines–“the massively bleeding patient”. Scand J Surg. 2008;97:15–36.

    PubMed  CAS  Google Scholar 

  54. Hess JR, Johansson PI, Holcomb JB. Trauma and massive transfusion. In: Mintz PD, editor. Transfusion therapy: clinical principles and practice. Bethesda: American Association of Blood Banks (AABB); 2010.

    Google Scholar 

  55. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, Adams PR, McCarthy JJ, Cotton BA. Admission rapid thrombelastography can replace conventional coagulation test in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256:476–86.

    Article  PubMed  Google Scholar 

  56. Hayward CP, Moffat KA, Raby A, Israels S, Plumhoff E, Flynn G, Zehnder JL. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010;134:955–63.

    Article  PubMed  Google Scholar 

  57. Uijttewaal WS, Nijhof EJ, Bronkhorst PJ, Den Hartog E, Heethaar RM. Near-wall excess of platelets induced by lateral migration of erythrocytes in flowing blood. Am J Physiol. 1993;264:H1239–44.

    PubMed  CAS  Google Scholar 

  58. Peyrou V, Lormeau JC, Herault JP, Gaich C, Pfliegger AM, Herbert JM. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost. 1999;81:400–6.

    PubMed  CAS  Google Scholar 

  59. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 1991;78:154–62.

    PubMed  CAS  Google Scholar 

  60. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol. 2006;26:41–8.

    Article  PubMed  CAS  Google Scholar 

  61. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 2006;53:S40–58.

    Article  PubMed  Google Scholar 

  62. Duchesne JC, Hunt JP, Wahl G, Marr AB, Wang YZ, Weintraub SE, Wright MJ, McSwain Jr NE. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma. 2008;65:272–6.

    Article  PubMed  Google Scholar 

  63. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248:447–58.

    PubMed  Google Scholar 

  64. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang. 2008;95:112–9.

    Article  PubMed  CAS  Google Scholar 

  65. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori VM, Roback JD. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion. 2010;50:1370–83.

    Article  PubMed  Google Scholar 

  66. Johansson PI, Oliveri R, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. A meta-analysis. J Emerg Trauma Shock. 2012;5:120–5.

    Article  PubMed  Google Scholar 

  67. Johansson PI, Hansen MB, Sorensen H. Transfusion practice in massively bleeding patients: time for a change? Vox Sang. 2005;89:92–6.

    Article  PubMed  CAS  Google Scholar 

  68. Johansson PI, Stensballe J, Rosenberg I, Hilslov TL, Jorgensen L, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47:593–8.

    Article  PubMed  Google Scholar 

  69. Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG, Shulman I, Nelson J, Demetriades D. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg. 2010;210:957–65.

    Article  PubMed  Google Scholar 

  70. Brown LM, Call MS, Margaret KM, Cohen MJ, Holcomb JB, Wade CE, Brasel KJ, Vercruysse G, MacLeod J, Dutton RP, Hess JR, Duchesne JC, McSwain NE, Muskat P, Johannigamn J, Cryer HM, Tillou A, Pittet JF, De Moya MA, Schreiber MA, Tieu B, Brundage S, Napolitano LM, Brunsvold M, Brunsvold M, Beilman G, Peitzman AB, Zenait MS, Sperry J, Alarcon L, Croce MA, Minei JP, Kozar R, Gonzalez EA, Stewart RM, Cohn SM, Mickalek JE, Bulger EM, Cotton BA, Nunez TC, Ivatury R, Meredith JW, Miller P, Pomper GJ, Marin B. A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J Trauma. 2011;71:S337–42.

    Article  PubMed  Google Scholar 

  71. Snyder CW, Weinberg JA, McGwin Jr G, Melton SM, George RL, Reiff DA, Cross JM, Hubbard-Brown J, Rue III LW, Kerby JD. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma. 2009;66:358–62.

    Article  PubMed  Google Scholar 

  72. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris Jr JA, Young PP, St Jacques P. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma. 2008;64:1177–82.

    Article  PubMed  Google Scholar 

  73. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma. 2009;66:41–8.

    Article  PubMed  Google Scholar 

  74. Duchesne JC, Kimonis K, Marr AB, Rennie KV, Wahl G, Wells JE, Islam TM, Meade P, Stuke L, Barbeau JM, Hunt JP, Baker CC, McSwain Jr NE. Damage control resuscitation in combination with damage control laparotomy: a survival advantage. J Trauma. 2010;69:46–52.

    Article  PubMed  Google Scholar 

  75. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma. 2009;66:S69–76.

    Article  PubMed  Google Scholar 

  76. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113:3406–17.

    Article  PubMed  CAS  Google Scholar 

  77. Johansson PI, Stensballe J. Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang. 2009;96:111–8.

    Article  PubMed  CAS  Google Scholar 

  78. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev. 2011;3:CD007871.

    Google Scholar 

  79. Johansson PI, Sørensen AM, Larsen C, Windeløv NA, Stensballe J, Perner A, Ostrowski SR. Low Hemorrhage-related mortality in trauma patients in a Level 1 Trauma Centre employing transfusion packages and early thrombelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion. 2013. doi:10.1111/trf.12214. [Epub ahead of print]

  80. Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs. 2002;62:2193–211.

    Article  PubMed  CAS  Google Scholar 

  81. CRASH-2 Trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.

    Article  PubMed  CAS  Google Scholar 

  82. Johansson PI, Ostrowski SR. Evidence supporting the use of recombinant activated factor vii in congenital bleeding disorders. Drug Des Devel Ther. 2010;4:107–16.

    Article  PubMed  CAS  Google Scholar 

  83. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B. Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69:489–500.

    Article  PubMed  CAS  Google Scholar 

  84. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791–800.

    Article  PubMed  CAS  Google Scholar 

  85. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360–5.

    PubMed  CAS  Google Scholar 

  86. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost. 2009;7:795–802.

    Article  PubMed  CAS  Google Scholar 

  87. Meyer MAS, Ostrowski SR, Windeløv NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients – what is the evidence? Vox Sang. 2011;101:185–90.

    Article  PubMed  CAS  Google Scholar 

  88. Pabinger-Fasching I. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate. Thromb Res. 2008;122 Suppl 2:S19–22.

    Article  PubMed  CAS  Google Scholar 

  89. Carvalho MC, Rodrigues AG, Conceicao LM, Galvao ML, Ribeiro LC. Prothrombin complex concentrate (Octaplex): a Portuguese experience in 1152 patients. Blood Coagul Fibrinolysis. 2012;23:222–8.

    Article  PubMed  CAS  Google Scholar 

  90. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:291–311.

    Article  PubMed  CAS  Google Scholar 

  91. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg. 2004;99:1564–9.

    Article  PubMed  CAS  Google Scholar 

  92. Chandler WL, Patel MA, Gravelle L, Soltow LO, Lewis K, Bishop PD, Spiess BD. Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2001;12:101–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet University of Copenhagen, Copenhagen, Denmark

    Pär I. Johansson MD, DMSc, MPA

  2. Department of Surgery, Center for Translational Injury Research (CeTIR), University of Texas Medical School – Houston, Houston, TX, USA

    Pär I. Johansson MD, DMSc, MPA

Authors
  1. Pär I. Johansson MD, DMSc, MPA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pär I. Johansson MD, DMSc, MPA .

Editor information

Editors and Affiliations

  1. Department of Surgery MSB 5.030, Center for Translational Injury Research, Houston, Texas, USA

    Anahita Dua

  2. Department of Surgery, University of Texas-Houston Duke University School of Medicine, Houston, Texas, USA

    Sapan S. Desai

  3. Department of Surgery, University of Texas-Houston, Houston, Texas, USA

    John B. Holcomb

  4. Department of Orthopedics, University of Texas-Houston, Houston, Texas, USA

    Andrew R. Burgess

  5. Department of Surgery, John Hopkins Medical Institutions, Baltimore, Maryland, USA

    Julie Ann Freischlag

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Johansson, P.I. (2014). Anticoagulation, Resuscitation, and Hemostasis. In: Dua, A., Desai, S., Holcomb, J., Burgess, A., Freischlag, J. (eds) Clinical Review of Vascular Trauma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39100-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39100-2_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39099-9

  • Online ISBN: 978-3-642-39100-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation